世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ジェネリック無菌注射剤の世界市場に関する洞察と2028年までの予測


Global Generic Sterile Injectable Market Insights and Forecast to 2028

ジェネリック無菌注射剤は、医療業界の広大な分野で多くの疾患や障害の治療に使用されているFDA承認生物製剤です。ジェネリック滅菌注射は、これらの薬の彼らのブランドの対応と比較して非常に安価であり、同様に... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年2月11日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

ジェネリック無菌注射剤は、医療業界の広大な分野で多くの疾患や障害の治療に使用されているFDA承認生物製剤です。ジェネリック滅菌注射は、これらの薬の彼らのブランドの対応と比較して非常に安価であり、同様によく実行されます。したがって、これらの注射剤は、すべての時間の需要に重く、世界中の病院や診療所の大半で使用されています。しかし、これらの注射の生産のための厳格な FDA 規制のため、これらの注射の厳格な需要の満足度は常に世界のジェネリック無菌注射市場の主要なプレーヤーのための一定の課題されています。

ジェネリック無菌注射剤市場は、無菌注射剤が様々な疾患や病状に適用されていることから、近い将来、安定した牽引力を獲得することが期待されています。メーカーは、注射剤の品質に妥協することなく需要の高まりに対応するため、ジェネリック無菌注射剤の増産に注力しています。
市場の分析と洞察。ジェネリック無菌注射剤の世界市場
COVID-19の大流行により、ジェネリック無菌注射剤の世界市場規模は2022年に5億6000万米ドル相当と推定され、レビュー期間中にCAGR5.8％で2028年までに78570万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年にジェネリック無菌注射剤世界市場の％を占めたモノクローナル抗体は、2028年までに100万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。
中国のジェネリック無菌注射剤の市場規模は2021年に百万米ドル、米国と欧州のジェネリック無菌注射剤はそれぞれ百万米ドル、百万米ドルと評価されています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％で、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％であった。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのジェネリック無菌注射剤の展望としては、ドイツが2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
ジェネリック無菌注射剤の世界の主要メーカーには、3M、Baxter Inc、Fresenius Kabi、Pfizer/Hospira、Novartis/Sandoz、Teva、Hikma、Sun Pharma、Dr. Reddy'sなどが挙げられます。2021年、世界の上位5社は売上高で約 %のシェアを持っています。

世界のジェネリック無菌注射剤の範囲とセグメント
ジェネリック無菌注射剤市場は、タイプ別と用途別に分類されます。世界のジェネリック無菌注射剤市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
モノクローナル抗体
サイトカイン
インスリン
ペプチドホルモン
ワクチン
その他
用途別セグメント
病院
薬局
オンライン薬局
会社別
3M
バクスター
フレゼニウス・カビ
ファイザー/ホスピーラ
ノバルティス/サンドウ
テバ
ヒグマ
サンファーマ
ドクター・レディーズ
マイラン
アストラゼネカ・ピーエルシー
メルク・アンド・カンパニー
ヘルベルク安全性 Ab
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.


ページTOPに戻る


目次

1 Study Coverage
1.1 Generic Sterile Injectable Product Introduction
1.2 Market by Type
1.2.1 Global Generic Sterile Injectable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Cytokines
1.2.4 Insulin
1.2.5 Peptide Hormones
1.2.6 Vaccines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Generic Sterile Injectable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Generic Sterile Injectable Sales Estimates and Forecasts 2017-2028
2.2 Global Generic Sterile Injectable Revenue Estimates and Forecasts 2017-2028
2.3 Global Generic Sterile Injectable Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Generic Sterile Injectable Sales by Region
2.4.1 Global Generic Sterile Injectable Sales by Region (2017-2022)
2.4.2 Global Sales Generic Sterile Injectable by Region (2023-2028)
2.5 Global Generic Sterile Injectable Revenue by Region
2.5.1 Global Generic Sterile Injectable Revenue by Region (2017-2022)
2.5.2 Global Generic Sterile Injectable Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Generic Sterile Injectable Sales by Manufacturers
3.1.1 Global Top Generic Sterile Injectable Manufacturers by Sales (2017-2022)
3.1.2 Global Generic Sterile Injectable Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Generic Sterile Injectable in 2021
3.2 Global Generic Sterile Injectable Revenue by Manufacturers
3.2.1 Global Generic Sterile Injectable Revenue by Manufacturers (2017-2022)
3.2.2 Global Generic Sterile Injectable Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Generic Sterile Injectable Revenue in 2021
3.3 Global Generic Sterile Injectable Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Generic Sterile Injectable Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Generic Sterile Injectable Sales by Type
4.1.1 Global Generic Sterile Injectable Historical Sales by Type (2017-2022)
4.1.2 Global Generic Sterile Injectable Forecasted Sales by Type (2023-2028)
4.1.3 Global Generic Sterile Injectable Sales Market Share by Type (2017-2028)
4.2 Global Generic Sterile Injectable Revenue by Type
4.2.1 Global Generic Sterile Injectable Historical Revenue by Type (2017-2022)
4.2.2 Global Generic Sterile Injectable Forecasted Revenue by Type (2023-2028)
4.2.3 Global Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
4.3 Global Generic Sterile Injectable Price by Type
4.3.1 Global Generic Sterile Injectable Price by Type (2017-2022)
4.3.2 Global Generic Sterile Injectable Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Generic Sterile Injectable Sales by Application
5.1.1 Global Generic Sterile Injectable Historical Sales by Application (2017-2022)
5.1.2 Global Generic Sterile Injectable Forecasted Sales by Application (2023-2028)
5.1.3 Global Generic Sterile Injectable Sales Market Share by Application (2017-2028)
5.2 Global Generic Sterile Injectable Revenue by Application
5.2.1 Global Generic Sterile Injectable Historical Revenue by Application (2017-2022)
5.2.2 Global Generic Sterile Injectable Forecasted Revenue by Application (2023-2028)
5.2.3 Global Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
5.3 Global Generic Sterile Injectable Price by Application
5.3.1 Global Generic Sterile Injectable Price by Application (2017-2022)
5.3.2 Global Generic Sterile Injectable Price Forecast by Application (2023-2028)
6 North America
6.1 North America Generic Sterile Injectable Market Size by Type
6.1.1 North America Generic Sterile Injectable Sales by Type (2017-2028)
6.1.2 North America Generic Sterile Injectable Revenue by Type (2017-2028)
6.2 North America Generic Sterile Injectable Market Size by Application
6.2.1 North America Generic Sterile Injectable Sales by Application (2017-2028)
6.2.2 North America Generic Sterile Injectable Revenue by Application (2017-2028)
6.3 North America Generic Sterile Injectable Market Size by Country
6.3.1 North America Generic Sterile Injectable Sales by Country (2017-2028)
6.3.2 North America Generic Sterile Injectable Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Generic Sterile Injectable Market Size by Type
7.1.1 Europe Generic Sterile Injectable Sales by Type (2017-2028)
7.1.2 Europe Generic Sterile Injectable Revenue by Type (2017-2028)
7.2 Europe Generic Sterile Injectable Market Size by Application
7.2.1 Europe Generic Sterile Injectable Sales by Application (2017-2028)
7.2.2 Europe Generic Sterile Injectable Revenue by Application (2017-2028)
7.3 Europe Generic Sterile Injectable Market Size by Country
7.3.1 Europe Generic Sterile Injectable Sales by Country (2017-2028)
7.3.2 Europe Generic Sterile Injectable Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Generic Sterile Injectable Market Size by Type
8.1.1 Asia Pacific Generic Sterile Injectable Sales by Type (2017-2028)
8.1.2 Asia Pacific Generic Sterile Injectable Revenue by Type (2017-2028)
8.2 Asia Pacific Generic Sterile Injectable Market Size by Application
8.2.1 Asia Pacific Generic Sterile Injectable Sales by Application (2017-2028)
8.2.2 Asia Pacific Generic Sterile Injectable Revenue by Application (2017-2028)
8.3 Asia Pacific Generic Sterile Injectable Market Size by Region
8.3.1 Asia Pacific Generic Sterile Injectable Sales by Region (2017-2028)
8.3.2 Asia Pacific Generic Sterile Injectable Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Generic Sterile Injectable Market Size by Type
9.1.1 Latin America Generic Sterile Injectable Sales by Type (2017-2028)
9.1.2 Latin America Generic Sterile Injectable Revenue by Type (2017-2028)
9.2 Latin America Generic Sterile Injectable Market Size by Application
9.2.1 Latin America Generic Sterile Injectable Sales by Application (2017-2028)
9.2.2 Latin America Generic Sterile Injectable Revenue by Application (2017-2028)
9.3 Latin America Generic Sterile Injectable Market Size by Country
9.3.1 Latin America Generic Sterile Injectable Sales by Country (2017-2028)
9.3.2 Latin America Generic Sterile Injectable Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Generic Sterile Injectable Market Size by Type
10.1.1 Middle East and Africa Generic Sterile Injectable Sales by Type (2017-2028)
10.1.2 Middle East and Africa Generic Sterile Injectable Revenue by Type (2017-2028)
10.2 Middle East and Africa Generic Sterile Injectable Market Size by Application
10.2.1 Middle East and Africa Generic Sterile Injectable Sales by Application (2017-2028)
10.2.2 Middle East and Africa Generic Sterile Injectable Revenue by Application (2017-2028)
10.3 Middle East and Africa Generic Sterile Injectable Market Size by Country
10.3.1 Middle East and Africa Generic Sterile Injectable Sales by Country (2017-2028)
10.3.2 Middle East and Africa Generic Sterile Injectable Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 3M
11.1.1 3M Corporation Information
11.1.2 3M Overview
11.1.3 3M Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 3M Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3M Recent Developments
11.2 Baxter Inc
11.2.1 Baxter Inc Corporation Information
11.2.2 Baxter Inc Overview
11.2.3 Baxter Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Inc Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Pfizer/Hospira
11.4.1 Pfizer/Hospira Corporation Information
11.4.2 Pfizer/Hospira Overview
11.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer/Hospira Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer/Hospira Recent Developments
11.5 Novartis/Sandoz
11.5.1 Novartis/Sandoz Corporation Information
11.5.2 Novartis/Sandoz Overview
11.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis/Sandoz Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis/Sandoz Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Hikma
11.7.1 Hikma Corporation Information
11.7.2 Hikma Overview
11.7.3 Hikma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hikma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Recent Developments
11.8 Sun Pharma
11.8.1 Sun Pharma Corporation Information
11.8.2 Sun Pharma Overview
11.8.3 Sun Pharma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sun Pharma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sun Pharma Recent Developments
11.9 Dr. Reddy’s
11.9.1 Dr. Reddy’s Corporation Information
11.9.2 Dr. Reddy’s Overview
11.9.3 Dr. Reddy’s Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dr. Reddy’s Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr. Reddy’s Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mylan Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 AstraZeneca Plc
11.11.1 AstraZeneca Plc Corporation Information
11.11.2 AstraZeneca Plc Overview
11.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 AstraZeneca Plc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Plc Recent Developments
11.12 Merck & Co., Inc
11.12.1 Merck & Co., Inc Corporation Information
11.12.2 Merck & Co., Inc Overview
11.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Merck & Co., Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck & Co., Inc Recent Developments
11.13 Hellberg Safety Ab
11.13.1 Hellberg Safety Ab Corporation Information
11.13.2 Hellberg Safety Ab Overview
11.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hellberg Safety Ab Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hellberg Safety Ab Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Generic Sterile Injectable Industry Chain Analysis
12.2 Generic Sterile Injectable Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Generic Sterile Injectable Production Mode & Process
12.4 Generic Sterile Injectable Sales and Marketing
12.4.1 Generic Sterile Injectable Sales Channels
12.4.2 Generic Sterile Injectable Distributors
12.5 Generic Sterile Injectable Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Generic Sterile Injectable Industry Trends
13.2 Generic Sterile Injectable Market Drivers
13.3 Generic Sterile Injectable Market Challenges
13.4 Generic Sterile Injectable Market Restraints
14 Key Findings in The Global Generic Sterile Injectable Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.

The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
Market Analysis and Insights: Global Generic Sterile Injectable Market
Due to the COVID-19 pandemic, the global Generic Sterile Injectable market size is estimated to be worth US$ 56020 million in 2022 and is forecast to a readjusted size of US$ 78570 million by 2028 with a CAGR of 5.8% during the review period. Fully considering the economic change by this health crisis, Monoclonal Antibodies accounting for % of the Generic Sterile Injectable global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Generic Sterile Injectable market size is valued at US$ million in 2021, while the US and Europe Generic Sterile Injectable are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Generic Sterile Injectable landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Generic Sterile Injectable include 3M, Baxter Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma and Dr. Reddy’s, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Generic Sterile Injectable Scope and Segment
Generic Sterile Injectable market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Generic Sterile Injectable market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Others
Segment by Application
Hospitals
Pharmacies
Online Pharmacies
By Company
3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy’s
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Generic Sterile Injectable Product Introduction
1.2 Market by Type
1.2.1 Global Generic Sterile Injectable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Cytokines
1.2.4 Insulin
1.2.5 Peptide Hormones
1.2.6 Vaccines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Generic Sterile Injectable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Generic Sterile Injectable Sales Estimates and Forecasts 2017-2028
2.2 Global Generic Sterile Injectable Revenue Estimates and Forecasts 2017-2028
2.3 Global Generic Sterile Injectable Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Generic Sterile Injectable Sales by Region
2.4.1 Global Generic Sterile Injectable Sales by Region (2017-2022)
2.4.2 Global Sales Generic Sterile Injectable by Region (2023-2028)
2.5 Global Generic Sterile Injectable Revenue by Region
2.5.1 Global Generic Sterile Injectable Revenue by Region (2017-2022)
2.5.2 Global Generic Sterile Injectable Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Generic Sterile Injectable Sales by Manufacturers
3.1.1 Global Top Generic Sterile Injectable Manufacturers by Sales (2017-2022)
3.1.2 Global Generic Sterile Injectable Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Generic Sterile Injectable in 2021
3.2 Global Generic Sterile Injectable Revenue by Manufacturers
3.2.1 Global Generic Sterile Injectable Revenue by Manufacturers (2017-2022)
3.2.2 Global Generic Sterile Injectable Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Generic Sterile Injectable Revenue in 2021
3.3 Global Generic Sterile Injectable Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Generic Sterile Injectable Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Generic Sterile Injectable Sales by Type
4.1.1 Global Generic Sterile Injectable Historical Sales by Type (2017-2022)
4.1.2 Global Generic Sterile Injectable Forecasted Sales by Type (2023-2028)
4.1.3 Global Generic Sterile Injectable Sales Market Share by Type (2017-2028)
4.2 Global Generic Sterile Injectable Revenue by Type
4.2.1 Global Generic Sterile Injectable Historical Revenue by Type (2017-2022)
4.2.2 Global Generic Sterile Injectable Forecasted Revenue by Type (2023-2028)
4.2.3 Global Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
4.3 Global Generic Sterile Injectable Price by Type
4.3.1 Global Generic Sterile Injectable Price by Type (2017-2022)
4.3.2 Global Generic Sterile Injectable Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Generic Sterile Injectable Sales by Application
5.1.1 Global Generic Sterile Injectable Historical Sales by Application (2017-2022)
5.1.2 Global Generic Sterile Injectable Forecasted Sales by Application (2023-2028)
5.1.3 Global Generic Sterile Injectable Sales Market Share by Application (2017-2028)
5.2 Global Generic Sterile Injectable Revenue by Application
5.2.1 Global Generic Sterile Injectable Historical Revenue by Application (2017-2022)
5.2.2 Global Generic Sterile Injectable Forecasted Revenue by Application (2023-2028)
5.2.3 Global Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
5.3 Global Generic Sterile Injectable Price by Application
5.3.1 Global Generic Sterile Injectable Price by Application (2017-2022)
5.3.2 Global Generic Sterile Injectable Price Forecast by Application (2023-2028)
6 North America
6.1 North America Generic Sterile Injectable Market Size by Type
6.1.1 North America Generic Sterile Injectable Sales by Type (2017-2028)
6.1.2 North America Generic Sterile Injectable Revenue by Type (2017-2028)
6.2 North America Generic Sterile Injectable Market Size by Application
6.2.1 North America Generic Sterile Injectable Sales by Application (2017-2028)
6.2.2 North America Generic Sterile Injectable Revenue by Application (2017-2028)
6.3 North America Generic Sterile Injectable Market Size by Country
6.3.1 North America Generic Sterile Injectable Sales by Country (2017-2028)
6.3.2 North America Generic Sterile Injectable Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Generic Sterile Injectable Market Size by Type
7.1.1 Europe Generic Sterile Injectable Sales by Type (2017-2028)
7.1.2 Europe Generic Sterile Injectable Revenue by Type (2017-2028)
7.2 Europe Generic Sterile Injectable Market Size by Application
7.2.1 Europe Generic Sterile Injectable Sales by Application (2017-2028)
7.2.2 Europe Generic Sterile Injectable Revenue by Application (2017-2028)
7.3 Europe Generic Sterile Injectable Market Size by Country
7.3.1 Europe Generic Sterile Injectable Sales by Country (2017-2028)
7.3.2 Europe Generic Sterile Injectable Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Generic Sterile Injectable Market Size by Type
8.1.1 Asia Pacific Generic Sterile Injectable Sales by Type (2017-2028)
8.1.2 Asia Pacific Generic Sterile Injectable Revenue by Type (2017-2028)
8.2 Asia Pacific Generic Sterile Injectable Market Size by Application
8.2.1 Asia Pacific Generic Sterile Injectable Sales by Application (2017-2028)
8.2.2 Asia Pacific Generic Sterile Injectable Revenue by Application (2017-2028)
8.3 Asia Pacific Generic Sterile Injectable Market Size by Region
8.3.1 Asia Pacific Generic Sterile Injectable Sales by Region (2017-2028)
8.3.2 Asia Pacific Generic Sterile Injectable Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Generic Sterile Injectable Market Size by Type
9.1.1 Latin America Generic Sterile Injectable Sales by Type (2017-2028)
9.1.2 Latin America Generic Sterile Injectable Revenue by Type (2017-2028)
9.2 Latin America Generic Sterile Injectable Market Size by Application
9.2.1 Latin America Generic Sterile Injectable Sales by Application (2017-2028)
9.2.2 Latin America Generic Sterile Injectable Revenue by Application (2017-2028)
9.3 Latin America Generic Sterile Injectable Market Size by Country
9.3.1 Latin America Generic Sterile Injectable Sales by Country (2017-2028)
9.3.2 Latin America Generic Sterile Injectable Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Generic Sterile Injectable Market Size by Type
10.1.1 Middle East and Africa Generic Sterile Injectable Sales by Type (2017-2028)
10.1.2 Middle East and Africa Generic Sterile Injectable Revenue by Type (2017-2028)
10.2 Middle East and Africa Generic Sterile Injectable Market Size by Application
10.2.1 Middle East and Africa Generic Sterile Injectable Sales by Application (2017-2028)
10.2.2 Middle East and Africa Generic Sterile Injectable Revenue by Application (2017-2028)
10.3 Middle East and Africa Generic Sterile Injectable Market Size by Country
10.3.1 Middle East and Africa Generic Sterile Injectable Sales by Country (2017-2028)
10.3.2 Middle East and Africa Generic Sterile Injectable Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 3M
11.1.1 3M Corporation Information
11.1.2 3M Overview
11.1.3 3M Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 3M Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3M Recent Developments
11.2 Baxter Inc
11.2.1 Baxter Inc Corporation Information
11.2.2 Baxter Inc Overview
11.2.3 Baxter Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Inc Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Pfizer/Hospira
11.4.1 Pfizer/Hospira Corporation Information
11.4.2 Pfizer/Hospira Overview
11.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer/Hospira Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer/Hospira Recent Developments
11.5 Novartis/Sandoz
11.5.1 Novartis/Sandoz Corporation Information
11.5.2 Novartis/Sandoz Overview
11.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis/Sandoz Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis/Sandoz Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Hikma
11.7.1 Hikma Corporation Information
11.7.2 Hikma Overview
11.7.3 Hikma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hikma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Recent Developments
11.8 Sun Pharma
11.8.1 Sun Pharma Corporation Information
11.8.2 Sun Pharma Overview
11.8.3 Sun Pharma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sun Pharma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sun Pharma Recent Developments
11.9 Dr. Reddy’s
11.9.1 Dr. Reddy’s Corporation Information
11.9.2 Dr. Reddy’s Overview
11.9.3 Dr. Reddy’s Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dr. Reddy’s Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr. Reddy’s Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mylan Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 AstraZeneca Plc
11.11.1 AstraZeneca Plc Corporation Information
11.11.2 AstraZeneca Plc Overview
11.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 AstraZeneca Plc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Plc Recent Developments
11.12 Merck & Co., Inc
11.12.1 Merck & Co., Inc Corporation Information
11.12.2 Merck & Co., Inc Overview
11.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Merck & Co., Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck & Co., Inc Recent Developments
11.13 Hellberg Safety Ab
11.13.1 Hellberg Safety Ab Corporation Information
11.13.2 Hellberg Safety Ab Overview
11.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Hellberg Safety Ab Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hellberg Safety Ab Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Generic Sterile Injectable Industry Chain Analysis
12.2 Generic Sterile Injectable Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Generic Sterile Injectable Production Mode & Process
12.4 Generic Sterile Injectable Sales and Marketing
12.4.1 Generic Sterile Injectable Sales Channels
12.4.2 Generic Sterile Injectable Distributors
12.5 Generic Sterile Injectable Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Generic Sterile Injectable Industry Trends
13.2 Generic Sterile Injectable Market Drivers
13.3 Generic Sterile Injectable Market Challenges
13.4 Generic Sterile Injectable Market Restraints
14 Key Findings in The Global Generic Sterile Injectable Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

QYResearch社のその他分野での最新刊レポート

本レポートと同じKEY WORD（injectable）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.